Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acutus Medical Inc (NQ: AFIB )

0.7539 -0.0271 (-3.47%)
Streaming Delayed Price Updated: 1:04 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 109,716
Open 0.7653
Bid (Size) 0.7418 (2)
Ask (Size) 0.7660 (6)
Prev. Close 0.7810
Today's Range 0.7380 - 0.7940
52wk Range 0.4800 - 2.150
Shares Outstanding 34,607,593
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical's Earnings: A Preview
 
Via Benzinga

Performance

YTD
-45.76%
-45.76%
1 Month
-49.74%
-49.74%
3 Month
-26.81%
-26.81%
6 Month
-9.68%
-9.68%
1 Year
-58.58%
-58.58%

More News

Read More
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via Globe NewsWire
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Looking Into Acutus Medical's Return On Capital Employed
Via Benzinga
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Reports Third Quarter 2022 Financial Results
From Acutus Medical, Inc.
Via Globe NewsWire
Earnings Preview For Acutus Medical
Via Benzinga
Acutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to Medtronic
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical to Announce Third Quarter 2022 Financial Results
From Acutus Medical, Inc.
Via Globe NewsWire
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Via Benzinga
Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via Globe NewsWire
Acutus Medical's Return On Capital Employed Overview
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.